The shares of Glenmark Pharmaceuticals went up 4.37 per cent to Rs 625.79 on the BSE after the company posted 108.02 per cent rise in net profit to Rs 130.14 crore on 48.69 per cent growth in total income to Rs 411.91 crore in Q4 March 2008 over Q4 March 2007.

<tr><td><p class='TableClas'></p><P class='TableClas'> <DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>The stock witnessed total volumes of 9.24 lakh share as against the two-week average volumes of 2.32 lakh shares. The company's net profit rose by 188.58 per cent to Rs 389.02 crore and total income grew 72.18 per cent to Rs 1392.74 crore in FY 2008 over FY 2007. </P></p></table>


Glenmark Pharma rises on good Q4 numbers

DALAL STREET SPIKES

More From This Section

Idea shares fall after Q3 earnings disappoint

BofA-Merrill raises Indiabulls to 'buy', stock gains

Suzlon stocks jump 17% on CDR approval

Maruti Suzuki rallies as Q3 profit beats analyst's estimates

Explore News